QP
MRSN

Quilter Plc’s Mersana Therapeutics MRSN Stock Holding History

Quilter Plc’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,800
Closed -$544K – 279
2019
Q4 		$544K Buy
+3,800
New +$278K 0.03% 136

Other funds holding MRSN

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

Quilter Plc's MRSN Position: Q1 2020 in Review

Quilter Plc sold out of Mersana Therapeutics (MRSN) in Q1 2020, closing a stake of 3,800 shares — an estimated $544K sold.

Quilter Plc first reported a position in MRSN in Q4 2019 and held it in 1 quarter. The position peaked at $544K in Q4 2019. 82 funds tracked by Wall St. Rank hold MRSN as of Q1 2020.

  • Quilter Plc reported no remaining Mersana Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Quilter Plc sold 3,800 Mersana Therapeutics shares in Q1 2020, an estimated $544K.
  • Quilter Plc first reported a position in Mersana Therapeutics in Q4 2019 and held it in 1 quarter.
  • Quilter Plc's Mersana Therapeutics position peaked at $544K in Q4 2019.
  • 82 funds tracked by Wall St. Rank held Mersana Therapeutics as of Q1 2020.

Based on Quilter Plc's 13F filing for Q1 2020, filed 8 May 2020.